Newsroom

SCHAUMBURG, Illinois--(BUSINESS WIRE)--Natus Sensory, leader globale nelle soluzioni sensoriali e diagnostiche, oggi ha annunciato la nomina di Arne Boye Nielsen nel proprio CdA, con effetto a partire dal 1 gennaio 2026. Arne apporta un'esperienza più che trentennale, a livello di alta dirigenza, nella tecnologia diagnostica e medicale, in particolare come presidente di Demant Diagnostics, di cui ha fondato e sviluppato l'attività nel corso di oltre trent'anni. Nel corso di questo mandato, Arne...

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 1/8/2026 Issue ¦ Holmes Master Issuer PLC 2023-2 Series 1 - Class A1 GBP 750,000,000 FRN due in October 2072     ISIN Number ¦ XS2669770773 ISIN Reference ¦ 266977077 Issue Nomin GBP ¦ 750000000 Period ¦ 10/15/2025 to 1/15/2026   Payment Date 1/15/2026 Number of Days ¦ 92 Rate ¦ 4.4731   Denomination GBP ¦ 1000   ¦ 750000000   ¦       Amount Payable per Denomination ¦ 11.27   ¦ 8455997.26   ¦      ...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Natus Sensory, een wereldleider in sensorische en diagnostische oplossingen, maakte vandaag de benoeming bekend van Arne Boye Nielsen bij haar Raad van Bestuur, met ingang van 1 januari 2026. Arne heeft meer dan 30 jaar leiderservaring als executive in diagnostiek en medische technologie, waarvan zijn rol als voorzitter van Demant Diagnostics het meest vermeldenswaard is, een bedrijf waar hij de activiteiten in een tijdsspanne van drie decennia uitbouwde tot e...

SCHAUMBURG, Illinois--(BUSINESS WIRE)--Natus Sensory, leader mondial des solutions sensorielles et diagnostiques, a annoncé aujourd’hui la nomination d’Arne Boye Nielsen au conseil d’administration, à compter du 1er janvier 2026. Arne apporte plus de 30 ans d’expérience en tant que cadre supérieur dans le domaine du diagnostic et des technologies médicales, notamment en tant que président de Demant Diagnostics, où il a développé et fait évoluer l’entreprise pour en faire un leader mondial en tr...

SCHAUMBURG, Illinois--(BUSINESS WIRE)--Natus Sensory, líder internacional en soluciones sensoriales y diagnósticas, ha anunciado hoy el nombramiento de Arne Boye Nielsen como miembro de su consejo de administración, con efecto a partir del 1 de enero de 2026. Arne cuenta con más de 30 años de experiencia en puestos de liderazgo ejecutivo en el ámbito del diagnóstico y la tecnología médica, sobre todo como presidente de Demant Diagnostics, donde construyó y expandió la empresa hasta convertirla...

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 1/8/2026 Issue ¦ Holmes Master Issuer PLC 2023-1 Series 1 - Class A1 GBP 750,000,000 FRN due October 2072     ISIN Number ¦ XS2584654151 ISIN Reference ¦ XS2584654235 Issue Nomin GBP ¦ 750000000 Period ¦ 10/15/2025 to 1/15/2026   Payment Date 1/15/2026 Number of Days ¦ 92 Rate ¦ 4.5131   Denomination GBP ¦ 1000   ¦ 750000000   ¦       Amount Payable per Denomination ¦ 11.38   ¦ 8531613.7   ¦       B...

RICHARDSON, Texas--(BUSINESS WIRE)--AdvoCare International, LLC, a leading health and wellness company, is proud to introduce the highly anticipated Daily Greens, a powerful new addition to its nutrition lineup. Perfect for those just starting on a health journey to wellness lovers, AdvoCare Daily Greens offers a simple, great-tasting way to help fill everyday nutrition gaps and keep you feeling your best, no matter how busy life gets. “AdvoCare Daily Greens is specifically designed for those w...

WEST DES MOINES, Iowa--(BUSINESS WIRE)--Sammons Institutional Group®, Inc., member company of Sammons Financial Group, announced today an enhanced strategy to further strengthen its support of financial institutions, reinforcing the firm’s long-standing commitment to serving distribution partners across the retirement marketplace. The initiative reflects continued investment in coverage, sales support, and specialized resources dedicated to helping financial institutions meet evolving client ne...

LYON, France--(BUSINESS WIRE)--ENYO Pharma (“ENYO”), a clinical-stage biopharmaceutical company developing innovative therapies for kidney diseases, today confirmed positive results from its Phase 2 Alpestria-1 study of vonafexor in patients with Alport syndrome. The data demonstrates that vonafexor, a highly differentiated FXR agonist, produced clinically meaningful improvements on kidney disease progression markers in a high-risk population already receiving standard of care (SoC) therapy. In...

EMERYVILLE, Calif.--(BUSINESS WIRE)--Tanium, a leader in Autonomous IT, announced today it has been recognized as a Leader in the inaugural 2026 Gartner Magic Quadrant for Endpoint Management Tools.1 Tanium believes this recognition reflects the strength of its industry-leading Autonomous IT Platform which unifies IT operations and security in a single solution, driven by AI and real-time intelligence. “Autonomous IT is redefining endpoint management which transitions manual, tool-centric appro...